참고문헌
- Pfuntner A, Wier LM, Stocks C. Most frequent conditions in U.S. Hospitals, 2011: Statistical Brief #162. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US), 2006.
- Lee GE, Lorch SA, Sheffler-Collins S, Kronman MP, Shah SS. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics 2010;126:204-13. https://doi.org/10.1542/peds.2009-3109
- Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect 2008;56:326-31. https://doi.org/10.1016/j.jinf.2008.02.018
- Niitu Y, Hasegawa S, Suetake T, Kubota H, Komatsu S, Horikawa M. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J Pediatr 1970;76:438-43. https://doi.org/10.1016/S0022-3476(70)80485-1
- Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010;16:613-6. https://doi.org/10.1111/j.1469-0691.2009.02968.x
- Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 2009;64:52-8. https://doi.org/10.1093/jac/dkp160
- Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis 2012;55:1642-9. https://doi.org/10.1093/cid/cis784
- Chang MW, Kim KH, Park ID, Song GY, Kim SW, Lee EY, et al. Isolation of Mycoplasma pneumoniae and antimicrobial susceptibilities of the isolates(III). J Life Sci 2005;15:479-85. https://doi.org/10.5352/JLS.2005.15.3.479
- Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis 2013;19:1281-4. https://doi.org/10.3201/eid1908.121455
- Lee E, Cho HJ, Hong SJ, Lee J, Sung H, Yu J. Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children. Korean J Pediatr 2017;60:151-7. https://doi.org/10.3345/kjp.2017.60.5.151
- Ahn HS, Shin HY, editors. Hong Chang Eui pediatrics. 11th ed. Seoul: Mirae N, 2016:697.
- Sensini A, Zuccherini F, Cerboni1 G, Galullo M, Meli L, Maso GD, et al. Serological diagnosis of Mycoplasma pneumoniae infection: a complicated puzzle. Microbiol Med 2012;27:171-6.
- Iwane MK, Prill MM, Lu X, Miller EK, Edwards KM, Hall CB, et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011;204:1702-10. https://doi.org/10.1093/infdis/jir634
- Hayden FG. Rhinovirus and the lower respiratory tract. Rev Med Virol 2004;14:17-31. https://doi.org/10.1002/rmv.406
- Jartti T, Lee WM, Pappas T, Evans M, Lemanske RF Jr, Gern JE. Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J 2008;32:314-20. https://doi.org/10.1183/09031936.00161907
- Garcia-Garcia ML, Calvo C, Pozo F, Villadangos PA, Perez-Brena P, Casas I. Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J 2012;31:808-13. https://doi.org/10.1097/INF.0b013e3182568c67
- Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835-45. https://doi.org/10.1056/NEJMoa1405870
- Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis 2011;52 Suppl 4:S284-9. https://doi.org/10.1093/cid/cir043
- Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53:e25-76. https://doi.org/10.1093/cid/cir531
- Jacobs JW, Lund PK, Potts JT Jr, Bell NH, Habener JF. Procalcitonin is a glycoprotein. J Biol Chem 1981;256:2803-7.
- Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000;26: 1193-200. https://doi.org/10.1007/s001340000624
- Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89:1512-25. https://doi.org/10.1210/jc.2002-021444
- Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28:977-83. https://doi.org/10.1097/00003246-200004000-00011
- Baer G, Baumann P, Buettcher M, Heininger U, Berthet G, Schafer J, et al. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial. PLoS One 2013;8:e68419. https://doi.org/10.1371/journal.pone.0068419
- Esposito S, Tagliabue C, Picciolli I, Semino M, Sabatini C, Consolo S, et al. Procalcitonin measurements for guiding antibiotictreatment in pediatric pneumonia. Respir Med 2011;105:1939-45. https://doi.org/10.1016/j.rmed.2011.09.003
- Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez JL, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001;84:332-6. https://doi.org/10.1136/adc.84.4.332
- Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000;19: 598-602. https://doi.org/10.1097/00006454-200007000-00003
- Stockmann C, Ampofo K, Killpack J, Williams DJ, Edwards KM, Grijalva CG, et al. Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia. J Pediatric Infect Dis Soc 2018;7:46-53. https://doi.org/10.1093/jpids/piw091
- Menendez R, Sahuquillo-Arce JM, Reyes S, Martinez R, Polverino E, Cilloniz C, et al. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest 2012;141: 1537-45. https://doi.org/10.1378/chest.11-1446
- Nascimento-Carvalho CM, Cardoso MR, Barral A, Araujo-Neto CA, Guerin S, Saukkoriipi A, et al. Procalcitonin is useful in identifying bacteraemia among children with pneumonia. Scand J Infect Dis 2010;42: 644-9. https://doi.org/10.3109/00365541003796775
피인용 문헌
- Early diagnostic value of the antimycoplasma antibody (IgM) inMycoplasma pneumoniaepneumonia: A single-center study in 2015 vol.7, pp.3, 2019, https://doi.org/10.4168/aard.2019.7.3.129
- Clinical efficacy of respiratory virus detection by using the FilmArray method in children admitted with respiratory infection vol.9, pp.1, 2018, https://doi.org/10.4168/aard.2021.9.1.12